Jason Fieber, Mr. Free at 33

This is My Largest Personal Stock Holding

I’m a huge fan of the company, and I have a good portion of my personal wealth invested in it. As the world grows bigger, older, and richer, demand for the products this company provides (which improve and save lives) should increase. As such, the odds are very good that shareholders will continue to profit and the dividend will continue to grow for decades to come.

Undervalued Dividend Growth Stock of the Week: Medtronic (MDT)

This is a high-quality healthcare firm that is positioned extremely favorably in regard to long-term, global demographic trends. These tailwinds are powerful, and the company is poised to continue pumping out growing dividends for many years to come. With the potential that shares are 15% undervalued on top of market-beating income, this is a compelling long-term dividend growth investment idea in the healthcare space.

Undervalued Dividend Growth Stock of the Week: Amgen, Inc. (AMGN)

This is a high-quality firm that’s extremely well positioned to capture plenty of growth from simple and long-term global trends. An incredible track record for growing its profit and dividend looks set to continue for many years to come. Meanwhile, the stock appears 13% undervalued and offers a yield near 3% on a well-funded dividend. Dividend growth investors would do well to strongly consider this stock for long-term investment.